52-Week Performance Chart

Powered by FactSet Research Systems Inc

No DR Special Notices are available.

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
BlackRock Fund Advisors 498,996
Goldman Sachs & Co. LLC (Private Banking) 415,465
Morgan Stanley & Co. International Plc 313,522
TOP MUTUAL FUND HOLDERS POSITION
iShares Biotechnology ETF 494,215
iShares IV Plc - NASDAQ US Biotechnology UCITS ETF 26,775
Fidelity Nasdaq Composite Index Fund 18,245

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol MESO
CUSIP 590717401
DR Venue NASDAQ Stock Market
DR ISIN US5907174016
Ratio DR:ORD 1:10
Underlying ISIN AU000000MSB8
Country Australia
Effective Date Nov 13, 2015
Depositary JPMC (Sponsored)
Industry Pharma. & Biotech.
Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Jul.25 15.26 7,181,257 326,421
Jun.25 10.89 3,850,496 192,525
May.25 10.64 4,710,527 224,311

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE